Montelukast improves respiratory disturbance and adenoid size in children with OSA
22:40 EDT 16 Aug 2012 | The Medical News
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory di..
Original Article: Montelukast improves respiratory disturbance and adenoid size in children with OSA
More From BioPortfolio on "Montelukast improves respiratory disturbance and adenoid size in children with OSA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
